A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis

Australian Clinical Research Network Pty Ltd, Maroubra

Sinclair Dermatology, East Melbourne

The Royal Children's Hospital, Parkville

Eastern Health, Box Hill

Veracity Clinical Research, Woolloongabba

The Skin Centre, Benowa

Penn State Hershey Medical Center, Hershey

PI-Coor Clinical Research, LLC, Burke

Pediatric Associates of Charlottesville, PLC, Charlottesville

Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville

Pediatric Research of Charlottesville, LLC, Charlottesville

Baumann Cosmetic and Research Institute, Miami

DS Research, Louisville

Ohio Pediatric Research Association, Inc., Dayton

Craig A. Spiegel, M.D., Bridgeton

Skin Specialists, PC, Omaha

Burke Pharmaceutical Research, Hot Springs

Oklahoma State University - Center for Health Sciences, Tulsa

Texas Dermatology and Laser Specialists, San Antonio

DermResearch, Inc., Austin

IMMUNOe Research Centers, Thornton

Tanner Clinic, Layton

Jordan Valley Dermatology Center, West Jordan

Rady Children's Hospital - San Diego/University of California, San Diego, San Diego

Rady Children's Hospital, San Diego

University of California, San Francisco, San Francisco

Oregon Health & Science University, Portland

Dermatology Specialists of Spokane, Spokane

Timber Lane Allergy & Asthma Research, LLC, South Burlington

Stollery Children's Hospital, Edmonton

Lynderm Research Inc., Markham

SKiN Centre for Dermatology, Peterborough